Must be the drugs
28 December 2018

Pot retailer Green Growth is mulling a hostile all-stock bid for the $2 bln Canadian grower. Synergies are negligible, the 46 pct premium is illusory and the target would lose listings in New York and Toronto. A brave try, but one Aphria would have to be high as a kite to accept.